Table 4.
Other modalities of HD and redox status.
| Authors | Groups | HD modality | TBARS/MDA | Protein carbonyls | GSSG | GSH | SOD | GPx | XO | CAT | TAC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canestrari et al., 1995 [89] | (a) 18 patients (age: 62.9 ± 13.9 yr) (b) 15 healthy subjects (age: 59.2 ± 8.3 yr) |
Peritoneal dialysis for 26.56 ± 23.27 months | (a) ↑RBC: 10.8 ± 3.8 Plasma: ↑74.5 ± 20.5 (b) RBC: 4.8 ± 2.6 Plasma: 46.6 ± 16.1 (nmol/g Hb or protein) |
(a) RBC: ↑0.039 ± 0.014 Plasma: 0.011 ± 0.006 (b) RBC: 0.012 ± 0.011 Plasma: 0.009 ± 0.005 (μmol/g Hb or protein) |
(a) RBC: 6.40 ± 1.36 Plasma: ↓1.53 ± 0.69 (b) RBC: 4.97 ± 0.78 Plasma: 2.07 ± 0.20 (μmol/g Hb or protein) |
(a) RBC: ↑48.7 ± 11.5 Plasma: 5.02 ± 1.36 (b) RBC: 36.1 ± 8.5 Plasma: 5.50 ± 0.79 (U/g Hb or protein) |
|||||
|
| |||||||||||
| Choi et al., 2011 [30] | (a) 18 patients (age: 48.1 ± 16.4 yr) (b) 18 patients (age: 52.0 ± 17 yr) (c) 16 healthy subjects (age: 48.9 ± 15.4 yr) |
(a) Peritoneal dialysis (PD) for 99.8 ± 39.4 months, 1.7x/wk (b) Typical HD for 94.3 ± 43.5 months, 3x/wk |
(a) ↑12.2 ± 3.5 (b) 13.0 ± 9.4 (c) 4.5 ± 0.9 (RLU) |
||||||||
|
| |||||||||||
| González-Diez et al., 2012 [90] | (a) 25 patients (b) 15 patients (age: —) |
(a) Haemodialfiltration (HFR) for 1 year (b) HD with polysulfone membrane for 1 year |
(a) ~19 (b) ~17 (μM) |
(a) ~2.2 (b) ~2.2 (nmol/mg protein) |
(a) ~1 (b) ~0.9 (μmoles/g) |
(a) ~2100 (b) ↓~1400 (U/g protein) |
(a) ~42 (b) ~34 (U/g protein) |
(a) ~18 (b) ~25 (U/g protein) |
(a) ~4 (b) ~4 (mM Trolox) |
||
TBARS: thiobarbituric acid reactive substances; Ox-LDL: oxidized low density lipoprotein; GSSG: oxidized glutathione; GSH: reduced glutathione; SOD: superoxide dismutase; GPx: glutathione peroxidase; XO: xanthine oxidase; CAT: catalase; TAC: total antioxidant capacity; yr: years; ↑: versus healthy, ↓: versus healthy, ~: values were estimated according to figures; ± stands for standard deviation.